FDA urges USPTO to tackle rising drug costs

14-09-2021

Muireann Bolger

FDA urges USPTO to tackle rising drug costs

Jarretera / Shutterstock.com

The US Food and Drug Administration (FDA) has urged the US Patent and Trademark Office (USPTO) to curb drug costs in the wake of President Joe Biden’s plan to promote competition in the pharmaceutical sector.


FDA, HHS, USPTO, drug costs, Joe Biden, executive order

LSIPR